Physician profile
Jesse Sengillo
NPI 1053803957
$4,453.75
in general payments reported to CMS, 2019-2025
13 companies · $781 in 2025
The $781 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $445 · 2020: $11.50 · 2021: $510 · 2022: $1,752 · 2023: $431 · 2024: $523 · 2025: $781.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,735.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,735.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,283.13 | 2019-2025 | Constellation, Clareon, Ngenuity |
| Bausch & Lomb Americas INC. | $575.85 | 2025 | Stellaris |
| Regeneron Healthcare Solutions, INC. | $500.11 | 2022-2025 | Eylea Hd |
| Novartis Pharmaceuticals Corporation | $258.35 | 2019 | |
| Alimera Sciences, INC. | $152.14 | 2022 | |
| Genentech, INC. | $150.98 | 2022 | |
| Glaukos Corporation | $147.82 | 2021 | |
| Horizon Therapeutics Plc | $118.35 | 2022 | |
| Amgen INC. | $116.46 | 2024 | Tepezza |
| Allergan, INC. | $83.70 | 2019 | |
| Apellis Pharmaceuticals, INC. | $24.19 | 2025 | Syfovre |
| Genentech USA, INC. | $24.02 | 2023 | Vabysmo |
| Carl Zeiss Meditec USA, INC. | $18.65 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jesse Sengillo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.